T-ALL
Oncology·MeSH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Approved(2)
Preclinical(1)
| Drug | Company |
|---|---|
| al101 | OLD AYALA, INC (AYLA) |
Compare drugs
Frequently asked questions
How many drugs are in development for T-ALL?
BioSniper tracks 3 drugs in development for T-ALL across 3 companies.
How many clinical trials target T-ALL?
There are 1 clinical trial targeting T-ALL tracked by BioSniper.
Deep-dive into T-ALL
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis